dm+d

356862006

Articles

Safety in Lactation: Drugs for hypertension

23 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Many of the drugs covered by…

What are the reported incidences of ankle oedema with different calcium channel blockers?

1 June 2020The potential to cause ankle oedema appears to exist for all calcium channel blocking agents, and is caused by increasing capillary pressure leading to leakage…

How should ankle oedema caused by calcium channel blockers be treated?

1 June 2020Ankle oedema is a common, often troublesome adverse effect for patients who are receiving calcium channel blocker (CCB) therapy, and may affect compliance. It is…
Search Articles

Medicine Compliance Aid Stability

ZanidipRecordati Pharmceuticals Ltd

Recordati Pharmceuticals Ltd
Zanidip
Tablets f/c 10mg, 20mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
If put into an MCA it should be opaque and protected from light, moisture and heat.
9 November 2015

Lactation Safety Information

Nifedipine, Verapamil
No published evidence of safety
Monitor infant for adverse effects
3 August 2020